Table 5.
Morbidity and mortality for the study period
| CPFE group | PF group | p value | |
|---|---|---|---|
| Hospitalization for respiratory causes during study period | 15/20 | 19/24 | NS |
| Lung cancer diagnosis prior to or during study period | 3/20a | 1/24b | NS |
| Lung cancer type | 2 small-cell; 1 non-small-cell | 1 small cell | |
| Other aerodigestive tract cancers | 1 esophageal cancer | 2 head and neck cancers | |
| Number receiving acute invasive mechanical ventilation during study period | 0/20 | 5/24 | 0.053 (NS) |
| Number receiving acute noninvasive ventilation during study period | 2/20 | 2/24 | NS |
| Mortality as of 4/1/08 (end of study period) | 13/20 (65%) | 17/24 (71%) | NS |
CPFE combined pulmonary fibrosis and emphysema, PF isolated pulmonary fibrosis
a
A fourth subject had a lung mass and cytology “suspicious” for lung cancer
b
A second subject had metastatic carcinoma, suspected lung primary